10 employees
Prexton Therapeutics has the mission to develop innovative drugs to improve the quality of life.
2012
$31M
from 5 investors over 5 rounds
Prexton Therapeutics raised $31M on February 7, 2017
Investors: Seroba-Kernel Ltd (Ireland), Forbion, Sunstone Life Science Ventures, M Ventures and Ysios Capital